Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04632238 · ClinicalTrials.gov registry record · NA

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

A NA study of Opioid Use Disorder and Substance Use Disorders, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
7,950
Enrollment target
4
Study locations

NCT04632238: Completed NA study of Opioid Use Disorder and Substance Use Disorders, sponsored by NYU Langone Health.

NCT04632238 is a NA study of Opioid Use Disorder and Substance Use Disorders that has completed, run by NYU Langone Health. The registered enrollment target is 7,950 participants, above the 4,625-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (72% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04632238, a NA study of Opioid Use Disorder and Substance Use Disorders, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
7,950 participants
Enrollment target
4
Study locations

Study Summary

This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have developed specific training and coaching protocols as well as electronic clinical support tools to guide quality improvement that can be disseminated within New York and the rest of the country. The study will test a clinic-level intervention that uses external facilitators to provide guidance to addictions clinics and contain three key components: 1) training on data driven management; 2) training and guidance on patient-centered care and OUD medication; and 3) electronic tools for shared decision making and patient progress monitoring.

Interventions

  • BEHAVIORAL Metrics-driven quality improvement (MDQI)

Study Locations (4)

New York

  • Samaritan Rockland - Outpatient Program - Blauvelt
  • Samaritan Queens - Jamaica IOP - Jamaica
  • Samaritan Daytop Village Harlem - Outpatient Program - New York
  • Upper Manhattan Addiction Treatment Services Program - New York

Trial Details

FieldValue
Enrollment Target 7,950 participants
Start Date 2020-07-01
Est. Completion 2025-06-30
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT04632238 record still lists

NCT04632238 is an interventional study that assigns participants to a tested intervention. Its 7,950 participants enrollment target places it among the larger protocols in the corpus, above the 4,625-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (72% higher).

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Metrics-driven quality improvement (MDQI) is the first listed.

NCT04632238 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04632238 about?

NCT04632238 is a clinical study titled "Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid". This project will develop and test quality measures for and a facilitation model to help addictions treatment clinics increase use of medicines for opioid use disorders, retain clients longer in care, and help more people move into successful recovery. At the end of the project, we will have develop...

What is the current status of trial NCT04632238?

This trial is currently completed. It is a NA study. The enrollment target is 7,950 participants. The study started on 2020-07-01. Estimated completion is 2025-06-30.

What conditions does trial NCT04632238 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Substance Use Disorders.

What interventions are being tested in trial NCT04632238?

The interventions under investigation include: Metrics-driven quality improvement (MDQI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04632238?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04632238 being conducted?

This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04632238's enrollment target sits among peer trials

7,950 7th of 257 higher than 251 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00539162 · 8,000 participants · NA

    Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

  • NCT00898638 · 8,000 participants

    Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

  • NCT02240862 · 8,000 participants

    The CREST-2 Registry

  • NCT03072927 · 8,000 participants

    MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04632238, the US trial registry maintained by the National Library of Medicine. NCT04632238 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.